File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1016/j.ijgo.2008.10.011
- Scopus: eid_2-s2.0-66549091745
- PMID: 19081564
- WOS: WOS:000264255600005
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Cost-effectiveness of misoprostol and prenatal iron supplementation as maternal mortality interventions in home births in rural India
Title | Cost-effectiveness of misoprostol and prenatal iron supplementation as maternal mortality interventions in home births in rural India |
---|---|
Authors | |
Keywords | Cost-effectiveness Home birth Iron supplementation Maternal mortality Misoprostol |
Issue Date | 2009 |
Citation | International Journal of Gynecology and Obstetrics, 2009, v. 104, n. 3, p. 189-193 How to Cite? |
Abstract | Objective: To determine the cost-effectiveness of prenatal iron supplementation and misoprostol use as interventions to prevent maternal mortality in home births in rural India. Methods: A cost-effectiveness analysis depicted three hypothetical cohorts of 10 000 pregnant women delivering at home in rural India: one with no intervention, one receiving standard prenatal iron supplements, and 1 receiving 600 μg of misoprostol in the third stage of labor. Results: Misoprostol used to prevent postpartum hemorrhage resulted in a 38% (95% CI, 5%-73%) decrease in maternal deaths, while prenatal iron supplementation resulted in a 5% (95% CI, 0%-47%) decrease. Misoprostol cost a median US $1401 (IQR US $1008-$1848) prenatal iron supplementation cost a median US $2241 (IQR No Lives Saved-$3882) per life saved compared with the standard care outcome. Conclusion: Misoprostol is a cost-effective maternal mortality intervention for home births. Iron supplementation may be worthwhile to improve women's health, but it is uncertain whether it can prevent mortality after hemorrhage. © 2008 Elsevier Ireland Ltd. All rights reserved. |
Persistent Identifier | http://hdl.handle.net/10722/326777 |
ISSN | 2023 Impact Factor: 2.6 2023 SCImago Journal Rankings: 0.951 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Sutherland, Tori | - |
dc.contributor.author | Bishai, David M. | - |
dc.date.accessioned | 2023-03-31T05:26:26Z | - |
dc.date.available | 2023-03-31T05:26:26Z | - |
dc.date.issued | 2009 | - |
dc.identifier.citation | International Journal of Gynecology and Obstetrics, 2009, v. 104, n. 3, p. 189-193 | - |
dc.identifier.issn | 0020-7292 | - |
dc.identifier.uri | http://hdl.handle.net/10722/326777 | - |
dc.description.abstract | Objective: To determine the cost-effectiveness of prenatal iron supplementation and misoprostol use as interventions to prevent maternal mortality in home births in rural India. Methods: A cost-effectiveness analysis depicted three hypothetical cohorts of 10 000 pregnant women delivering at home in rural India: one with no intervention, one receiving standard prenatal iron supplements, and 1 receiving 600 μg of misoprostol in the third stage of labor. Results: Misoprostol used to prevent postpartum hemorrhage resulted in a 38% (95% CI, 5%-73%) decrease in maternal deaths, while prenatal iron supplementation resulted in a 5% (95% CI, 0%-47%) decrease. Misoprostol cost a median US $1401 (IQR US $1008-$1848) prenatal iron supplementation cost a median US $2241 (IQR No Lives Saved-$3882) per life saved compared with the standard care outcome. Conclusion: Misoprostol is a cost-effective maternal mortality intervention for home births. Iron supplementation may be worthwhile to improve women's health, but it is uncertain whether it can prevent mortality after hemorrhage. © 2008 Elsevier Ireland Ltd. All rights reserved. | - |
dc.language | eng | - |
dc.relation.ispartof | International Journal of Gynecology and Obstetrics | - |
dc.subject | Cost-effectiveness | - |
dc.subject | Home birth | - |
dc.subject | Iron supplementation | - |
dc.subject | Maternal mortality | - |
dc.subject | Misoprostol | - |
dc.title | Cost-effectiveness of misoprostol and prenatal iron supplementation as maternal mortality interventions in home births in rural India | - |
dc.type | Article | - |
dc.description.nature | link_to_subscribed_fulltext | - |
dc.identifier.doi | 10.1016/j.ijgo.2008.10.011 | - |
dc.identifier.pmid | 19081564 | - |
dc.identifier.scopus | eid_2-s2.0-66549091745 | - |
dc.identifier.volume | 104 | - |
dc.identifier.issue | 3 | - |
dc.identifier.spage | 189 | - |
dc.identifier.epage | 193 | - |
dc.identifier.isi | WOS:000264255600005 | - |